1.38
+0.05(+3.76%)
Currency In USD
Previous Close | 1.33 |
Open | 1.42 |
Day High | 1.43 |
Day Low | 1.33 |
52-Week High | 12.7 |
52-Week Low | 1.26 |
Volume | 248,563 |
Average Volume | 628,844 |
Market Cap | 4.45M |
PE | -0.06 |
EPS | -21.94 |
Moving Average 50 Days | 2.21 |
Moving Average 200 Days | 3.49 |
Change | 0.05 |
If you invested $1000 in 60 Degrees Pharmaceuticals, Inc. (SXTP) since IPO date, it would be worth $4.91 as of July 31, 2025 at a share price of $1.38. Whereas If you bought $1000 worth of 60 Degrees Pharmaceuticals, Inc. (SXTP) shares 1 year ago, it would be worth $155.93 as of July 31, 2025 at a share price of $1.38.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria
GlobeNewswire Inc.
Jul 17, 2025 12:01 PM GMT
Study will evaluate activity of tafenoquine against vector-borne pathogens, Borrelia (Lyme disease) and Bartonella in cell cultureBorrelia and Bartonella, together with Babesia, represent the "3Bs," pathogens most often present in individuals with ti
60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering
GlobeNewswire Inc.
Jul 16, 2025 8:01 PM GMT
$5 million received upfront with up to an additional $5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrantsWASHINGTON, July 16, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (the “Company” or “
60 Degrees Pharmaceuticals Announces Pricing of Up to $10 Million Public Offering
GlobeNewswire Inc.
Jul 15, 2025 1:10 PM GMT
$5 million upfront with up to an additional $5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrantsWASHINGTON, July 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (the “Company” or “60 Degree